SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NexStar Pharm(NXTR) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (248)12/10/1997 5:25:00 PM
From: Biomaven  Read Replies (1) | Respond to of 328
 
Miljenko,

In case you didn't see it yet, more Ambisome data from the conference:

biz.yahoo.com

Seems to be more details from the Phase III trials comparing it to Ampho B. Nothing that looked too spectacular to me. I guess that the reduced nephrotoxicity is going to be their strongest selling point.

Any comments?

Peter